NUCB2 and breast cancer: To our knowledge, this is the first report to reveal that high NUCB2/Nesfatin-1 might promote breast cancer progression via upregulation of cholesterol synthesis depending on the mTORC1/SREBPS/HMGCR axis (Fig. 7).